Skip to main content

Advertisement

SpringerLink
Log in

The detection and management of dysplastic nevi and early melanoma

  • World Progress In Surgery
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Worldwide, the incidence and mortality rates for melanoma are increasing at an alarming rate. Recently, the recognition of dysplastic nevi as markers and potential precursors for melanoma has identified one group of individuals with an increased risk to develop this disease. Close surveillance of these individuals should improve the ability of clinicians to detect melanoma at an early stage when surgical excision of the primary tumor is curative in the majority of patients.

Résumé

Dans le monde entier, l'incidence du mélanome et la mortalité qui en découle augmentent de manière alarmante. Récemment, l'identification de certains naevi comme marqueurs et précurseurs potentiels de mélanome, a permis l'individualisation d'un groupe de sujet à haut risque pour développer un mélanome. Une surveillance étroite de cette population, à un stade où l'excision chirurgicale de la tumeur primitive peut être curative, devrait permettre d'augmenter le nombre de cas détectés par les cliniciens à un stade utile.

Resumen

En todo el mundo se informa un incremento alarmante en las tasas de incidencia y de mortalidad por melanoma. Recientemente se ha demostrado que los nevus displásicos son marcadores y precursores potenciales de melanoma, lo cual permite identificar un grupo poblacional con mayor riesgo de desarrollar esta enfermedad. El seguimiento cuidadoso de las personas que conforman este grupo debe mejorar la capacidad de la detección clínica del melanoma en una etapa temprana de su evolución, cuando la resección quirúrgica del neoplasma primario resulta curativa en la mayoría de lo pacientes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boring, C.C., Squires, T.S., Tong, T.: Cancer statistics, 1991. CA41:19, 1991

    PubMed  Google Scholar 

  2. Koh, H.K., Clapp, R.W., Barnett, J.M., Nannery, W.M., Tahan, S.R., Geller, A.C., Bhawan, J., Harrist, T.J., Kwan, T., Stadecker, M., Okun, M.R., Dong, J.A., Beattie, M., Prout, M.N., Murphy, G.F.: Systemic underreporting of cutaneous malignant melanoma in Massachusetts. J. Am. Acad. Dermatol.24:545, 1991

    PubMed  Google Scholar 

  3. Evans, R.D., Kopf, A.W., Lew, R.A., Rigel, D.S., Bart, R.S., Friedman, R.J., Rivers, J.K.: Risk factors for the development of malignant melanoma—I: Review of case-control studies. J. Dermatol. Surg. Oncol.14:393, 1988

    PubMed  Google Scholar 

  4. Koh, H.K., Geller, A.C., Miller, D.R., Caruso, A., Gage, I., Lew, R.A.: Who is being screened for melanoma/skin cancer? J. Am. Acad. Dermatol.24:271, 1991

    PubMed  Google Scholar 

  5. Koh, H.K., Lew, R.A., Prout, M.N.: Screening for a melanoma/skin cancer: Theoretic and practical considerations. J. Am. Acad. Dermatol.20:159, 1989

    PubMed  Google Scholar 

  6. Masri, G.D., Clark, W.H. Jr., Guerry, D., Halpern, A., Thompson, C.J., Elder, D.E.: Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J. Am. Acad. Dermatol.22:1042, 1990

    PubMed  Google Scholar 

  7. Girgis, A., Campbell, E.M., Redman, S., Sanson-Fisher, R.W.: Screening for melanoma: A community survey of prevalence and predictors. Med. J. Aust.154:338, 1991

    PubMed  Google Scholar 

  8. Nichols, S.: Effect of a public campaign about the malignant melanoma on general practitioner workload in South Hampton. Br. Med. J.296:15, 1988

    Google Scholar 

  9. Whitehead, S.M., Roughton, M.A., Elwood, J.M., Davison, J., Steward, M.: Effects of a health education campaign for the earlier diagnosis of melanoma. Br. J. Cancer60:421, 1989

    PubMed  Google Scholar 

  10. Graham-Brown, R.A.C., Osborne, J.E., London, S.P., Fletcher, A., Shaw, D., Williams, B., Bowry, D.: The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br. J. Dermatol.122:53, 1990

    PubMed  Google Scholar 

  11. Clark, W.H., Reimer, R.R., Greene, M., Ainsworth, A.M., Mastrangelo, M.J.: Origin of familial malignant melanomas from heritable melanocytic lesions. Arch. Dermatol.114:732, 1978

    PubMed  Google Scholar 

  12. Rhodes, A.R.: Acquired dysplastic melanocytic nevi and cutaneous melanoma: Precursors and prevention. Ann. Int. Med.102:546, 1985

    PubMed  Google Scholar 

  13. Kelly, J.W., Crutcher, W.A., Sagebiel, R.W.: Clinical diagnosis of dysplastic nevi. J. Am. Acad. Dermatol.14:1044, 1986

    PubMed  Google Scholar 

  14. Friedman, R.J., Heilman, E.R., Rigel, D.S., Kopf, A.W.: The dysplastic nevus: Clinical and pathologic features. Dermatol. Clin.3:239, 1985

    PubMed  Google Scholar 

  15. Greene, M.H., Clark, W.H. Jr., Tucker, M.A., Kraemer, K.H., Elder, D.E., Fraser, M.C.: High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann. Int. Med.102:458, 1985

    PubMed  Google Scholar 

  16. Rigel, D.S., Rivers, J.K., Kopf, A.W., Friedman, R.J., Vinokur, A.F., Heilman, E.R., Levenstein, M.: Dysplastic nevi: Markers for increased risk for melanoma. Cancer63:386, 1989

    PubMed  Google Scholar 

  17. Holly, E.A., Kelly, J.W., Shpall, S.N., Chiu, S-H.: Number of melanocytic nevi as a major risk factor for malignant melanoma. J. Am. Acad. Dermatol.17:459, 1987

    PubMed  Google Scholar 

  18. Grob, J.J., Gouvernet, J., Aymar, D., Mostaque, A., Romano, M.H., Collet, A.M., Noe, M.C., Diconstanzo, M.P., Bonerandi, J.J.: Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer66:387, 1990

    PubMed  Google Scholar 

  19. Greene, M.H., Clark, W.H. Jr., Tucker, M.A., Elder, D.E., Kraemer, K.H., Guerry, D. 4th., Witmer, K.W., Thompson, J., Matozzo, I., Fraser, M.C.: Acquired precursors of cutaneous malignant melanoma: The familial dysplastic nevus syndrome. N. Engl. J. Med.312:91, 1985

    PubMed  Google Scholar 

  20. Grin, C.M., Kopf, A.W., Welkovich, B., Bart, R.S., Levenstein, M.J.: Accuracy in the clinical diagnosis of malignant melanoma. Arch. Dermatol.127:763, 1990

    Google Scholar 

  21. Sober, A.J., Fitzpatrick, T.B., Mihm, M.C., Wise, T.G., Pearson, B.J., Clark, W.H., Kopf, A.W.: Early recognition of cutaneous melanoma. J.A.M.A.242:2795, 1979

    PubMed  Google Scholar 

  22. Keefe, M., Dick, D.C., Wakeel, R.A.: A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin. Exp. Dermatol.15:167, 1990

    PubMed  Google Scholar 

  23. Wick, M.W., Sober, A.J., Fitzpatrick, T.B., Mihm, M.C., Kopf, A.W., Clark, W.H. Jr., Blois, M.S.: Clinical characteristics of early cutaneous melanoma. Cancer45:2684, 1980

    PubMed  Google Scholar 

  24. Rivers, J.K., Kopf, A.W., Vinokur, A.F., Rigel, D.S., Friedman, R.J., Heilman, E.R., Levenstein, M.: Clinical characteristics of malignant melanomas developing in persons with dysplastic nevi. Cancer65:1232, 1990

    PubMed  Google Scholar 

  25. Lederman, J.S., Fitzpatrick, T.B., Sober, A.J.: Skin markings in the diagnosis and prognosis of cutaneous melanoma. Arch. Dermatol.120:1449, 1984

    PubMed  Google Scholar 

  26. Slue, W., Kopf, A.W., Rivers, J.K.: Total-body photographs of dysplastic nevi. Arch. Dermatol.124:1239, 1988

    PubMed  Google Scholar 

  27. Pehamberger, H., Steiner, A., Wolff, K.: In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J. Am. Acad. Dermatol.17:571, 1987

    PubMed  Google Scholar 

  28. Steiner, A., Pehamberger, H., Wolff, K.: In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma. J. Am. Acad. Dermatol.17:584, 1987

    PubMed  Google Scholar 

  29. Srivastava, A., Hughes, L.E., Woodcock, J.P., Laidler, P.: Vascularity in cutaneous melanoma detected by Doppler sonography and histology: Correlation with tumour behaviour. Br. J. Cancer59:89, 1989

    PubMed  Google Scholar 

  30. Dhawan, A.P.: Early detection of cutaneous malignant melanoma by three-dimensional nevoscopy. Comput. Methods Programs Biomed.21:59, 1985

    PubMed  Google Scholar 

  31. Murray, A.E., Neill, S.M., Harland, C.C., Rowland-Payne, C.M.E., Staughton, R.C.D., Copeman, P.W.M.: A new method for the quantification of physical change in unstable pigmented lesions using digital image processing techniques. Br. J. Dermatol.119 (Supp 33):45, 1988

    PubMed  Google Scholar 

  32. McCarthy, W.H., Rivers, J.K.: Can early melanoma be diagnosed? In Cutaneous Melanoma, Biology and Management, N. Cascinelli, M. Santinami, U. Veronesi, editors, Milan, Masson, 1990, pp. 113–125

    Google Scholar 

  33. Rapini, R.P.: Photographs for Clarks “dysplastic” nevi? J. Am. Acad. Dermatol.19:1130, 1988

    PubMed  Google Scholar 

  34. Gallagher, R.P., McLean, D.I., Yang, P., Coldman, A.J., Silver, H.K.B., Spinelli, J.J., Beagrie, M.: Anatomic distribution of acquired melanocytic nevi in white children. Arch. Dermatol.125:466, 1990

    Google Scholar 

  35. Rigel, D.S., Friedman, R.J., Kopf, A.W., Weltman, R., Prioleau, P.G., Safai, B., Lebwohl, M.G., Eliezri, H., Torre, D.P., Binford, R.T. Jr., Cipollaro, V.A., Biro, L., Charbonneau, D., Mosettis, A.: Importance of complete cutaneous examination for the detection of malignant melanoma. J. Am. Acad. Dermatol.14:857, 1986

    PubMed  Google Scholar 

  36. Rigel, D.S., Friedman, R.J., Kopf, A.W.: Surgical margins for removal of dysplastic nevi. J. Dermatol. Surg. Oncol.11:745, 1985

    Google Scholar 

  37. Duray, P.H., Livolsi, V.A.: Recurrent dysplastic nevus following shave excision. J. Dermatol. Surg. Oncol.10:811, 1984

    PubMed  Google Scholar 

  38. Elder, D.E., Clark, W.H.: Developmental biology of malignant melanoma. In Pathobiology of Malignant Melanoma, D.E. Elder, editor, Basel, Karger, 1987, pp. 1–28

    Google Scholar 

  39. Barnes, L.M., Norlund, J.J.: The natural history of dysplastic nevi: A case illustrating their evolution. Arch. Dermatol.123:1059, 1987

    PubMed  Google Scholar 

  40. Green, M.H., Clark, W.H., Tucker, M.A., Elder, D.E., Kraemer, K.H., Guerry, D., Fraser, M.C.: Managing the dysplastic naevus syndrome. Lancet1:166, 1984

    Google Scholar 

  41. Meyskens, F.L., Edwards, L., Levine, N.S.: Role of topical tretinoin in melanoma and dysplastic nevi. J. Am. Acad. Dermatol.15:822, 1986

    PubMed  Google Scholar 

  42. Edwards, L., Jaffe, P.: The effect of topical tretinoin on dysplastic nevi: A preliminary trial. Arch. Dermatol.126:494, 1990

    PubMed  Google Scholar 

  43. Edwards, L., Meyskens, F., Levine, N.: Effect of oral isotretinoin on dysplastic nevi. J. Am. Acad. Dermatol.20:257, 1989

    PubMed  Google Scholar 

  44. Rivers, J.K., McArdle, C.A., Gupta, G., McCarthy, S.W., O'Brien, C.J., McCarthy, W.H.: Recurrent melanoma after topical tretinoin. Lancet2:1393, 1989

    Google Scholar 

  45. Kopf, A.W., Goldman, R.J., Rivers, J.K., Levenstein, M., Rigel, D.S., Friedman, R.J., Bart, R.S.: Skin types in dysplastic nevus syndrome. J. Dermatol. Surg. Oncol.14:827, 1988

    PubMed  Google Scholar 

  46. Ledwig, P.A., Robinson, J.K.: Should excisional biopsy of clinically probable melanomas include a margin that might also serve as adequte for treatment? Arch. Dermatol.126:877, 1990

    PubMed  Google Scholar 

  47. Epstein, E., Bragg, K., Linden, G.: Biopsy and prognosis of malignant melanoma. J.A.M.A.208:1369, 1969

    PubMed  Google Scholar 

  48. Lederman, J.S., Sober, A.J.: Does biopsy type influence survival in clinical stage 1 cutaneous melanoma? J. Am. Acad. Dermatol.13:983, 1985

    PubMed  Google Scholar 

  49. Balch, C.M.: Excising melanomas: How wide is enough? And how to reconstruct? J. Surg. Oncol.44:135, 1990

    PubMed  Google Scholar 

  50. Clark, W.H., Elder, D.E., Guerry, D., Braitman, L.E., Trock, B.J., Schultz, D., Synnestvedt, M., Halpern, A.C.: Model predicting survival in stage I melanoma based on tumor progression. J. Natl. Cancer Inst.81:1893, 1989

    PubMed  Google Scholar 

  51. Veronesi, U., Cascinelli, N., Adamus, J., Balch, C., Bandiera, D., Barchuk, A., Bufalino, R., Craig, P., De Marsillac, J., Durand, J.C., Van Geel, A.N., Holstrom, H., Hunter, J.A., Jorgensen, O.G., Kiss, B., Kroon, B., Lacour, J., Lejeune, F., Mackie, R., Mechl, Z., Mitrov, G., Morabito, A., Nosek, H., Panizzon, R., Prade, M., Santi, P., Van Slooten, E., Tomin, R., Trapeznikov, N., Tsanov, T., Urist, M., Wozniak, K.D.: Thin stage I primary cutaneous malignant melanoma: Comparisons of excision with margins of 1 or 3 cm. N. Engl. J. Med.318:1159, 1988

    PubMed  Google Scholar 

  52. Evans, J., McCann, B.G.: A new protocol for the treatment of stage I cutaneous malignant melanoma: Interim results of the first 806 patients treated. Br. J. Plast. Surg.43:426, 1990

    PubMed  Google Scholar 

  53. McEwan, L., Smith, J.G., Matthews, J.P.: Late recurrence of localized cutaneous melanoma: Its influence on follow-up policy. Plast. Reconstr. Surg.86:527; 1990

    PubMed  Google Scholar 

  54. Ariyan, A.: Plastic and reconstructive surgery in melanoma patients. In Pigment Cell, C.M. Balch, editor, New York, Karger, 1985, pp. 181–205

    Google Scholar 

  55. Dinehart, S.M., Pollack, S.V.: Mohs micrographic surgery for skin cancer. Cancer Treat. Rev.16:257, 1989

    PubMed  Google Scholar 

  56. Dhawan, S.S., Wolf, D.J., Rabinovitz, H.S., Poulos, E.: Lentigo maligna: The use of rush permanent sections in therapy. Arch. Dermatol.126:928, 1990

    PubMed  Google Scholar 

  57. Harwood, A.R.: Conventional fractionated radiotherapy for 51 patients with lentigo maligna melanoma. Int. J. Radiat. Oncol. Biol. Phys.9:1019, 1983

    PubMed  Google Scholar 

  58. McLean, D.I., Peter, K.K.: Apparent progression of lentigo maligna to invasive melanoma during treatment with topical azelaic acid. Br. J. Dermatol.114:685, 1986

    PubMed  Google Scholar 

  59. Rivers, J.K., McCarthy, W.H.: No effect of topical tretinoin on lentigo maligna. Arch. Dermatol.127:129, 1991

    Google Scholar 

  60. Urist, M.M., Balch, C.M., Soong, S.-J., Milton, G.W., Shaw, H.M., McGovern, V.J., Murad, T.M., McCarthy, W.H., Maddox, W.A.: Head and neck melanoma in 534 clinical stage I patients: A prognostic factors analysis and results of surgical treatment. Ann. Surg.200:769, 1984

    PubMed  Google Scholar 

  61. Michalik, E.E., Fitzpatrick, T.B., Sober, A.J.: Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma: Report of two cases. Arch. Dermatol.119:831, 1983

    PubMed  Google Scholar 

  62. Rogers, G.S., Kopf, A.W., Rigel, D.S., Friedman, R.J., Levenstein, M., Bart, R.S.: Hazard-rate analysis in stage I malignant melanoma. Arch. Dermatol.122:999, 1986

    PubMed  Google Scholar 

  63. McCarthy, W.H., Shaw, H.M., Thompson, J.F., Milton, G.W.: Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg. Gynecol. Obstet.166:497, 1988

    PubMed  Google Scholar 

  64. Kelly, J.W., Blois, M.S., Sagebiel, R.W.: Frequency and duration of patient follow-up after treatment of a primary malignant melanoma. J. Am. Acad. Dermatol.13:756, 1985

    PubMed  Google Scholar 

  65. Ho, V.C., Sober, A.J.: Therapy for cutaneous melanoma: An update. J. Am. Acad. Dermatol.22:159, 1990

    PubMed  Google Scholar 

  66. Iscoe, N., Kersey, R.N., Gapski, J., Osoba, D., From, L., DeBoer, G., Quirt, I.: Predictive value of staging investigations in patients with clinical stage I malignant melanoma. Plast. Reconstr. Surg.80:233, 1987

    PubMed  Google Scholar 

  67. Marks, R., McCarthy, W.H.: Skin cancer: Increasing incidence and public awareness. Med. J. Aust.153:505, 1990

    PubMed  Google Scholar 

  68. Williams, H.C., Smith, D., Du Vivier, A.W.P.: Evaluation of public education campaigns in cutaneous melanoma: The King's College Hospital experience. Br. J. Dermatol.123:85, 1990

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Division of Dermatology and The British Columbia Cancer Agency, The University of British Columbia, Vancouver, British Columbia, Canada

    Jason K. Rivers M.D. (F.R.C.P.C.)

Authors
  1. Jason K. Rivers M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rivers, J.K. The detection and management of dysplastic nevi and early melanoma. World J. Surg. 16, 166–172 (1992). https://doi.org/10.1007/BF02071516

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02071516

Keywords

Search

Navigation